In particular, high GSDMB expression was significantly related to the poor prognosis of KIRC patients, whereas low GSDMB expression was associated with poor prognosis of BLCA and SKCM patients (Figure 2A). Here, GSDMB is linked to bladder transitional cell carcinoma.